Exact Mass: 700.5641596
Exact Mass Matches: 700.5641596
Found 500 metabolites which its exact mass value is equals to given mass value 700.5641596
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
SM(d18:1/16:1(9Z))
Sphingomyelin (d18:1/16:1(9Z)) or SM(d18:1/16:1(9Z)) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. SM(d18:1/16:1(9Z)) consists of a sphingosine backbone and a palmitoleic acid chain. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SM has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition, it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2, an enzyme that breaks down sphingomyelin into ceramide, has been found to localize exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme sphingomyelinase, which causes the accumulation of sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.
SM(d18:2(4E,14Z)/16:0)
Sphingomyelin (d18:2(4E,14Z)/16:0) or SM(d18:2(4E,14Z)/16:0) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. SM(d18:2(4E,14Z)/16:0) consists of a sphinga-4E,14Z-dienine backbone and a palmitic acid chain. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SM has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition, it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2, an enzyme that breaks down sphingomyelin into ceramide, has been found to localize exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme sphingomyelinase, which causes the accumulation of sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.
DG(21:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)
DG(21:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/21:0/0:0)
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))
DG(21:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/21:0)
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(21:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)
DG(21:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/21:0/0:0)
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))
DG(21:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/21:0)
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(21:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)
DG(21:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/21:0/0:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))
DG(21:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/21:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(21:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)
DG(21:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/21:0/0:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))
DG(21:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/21:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(21:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)
DG(21:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/21:0/0:0)
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))
DG(21:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/21:0)
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(21:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)
DG(21:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/21:0/0:0)
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))
DG(21:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/21:0)
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)
DG(a-21:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-21:0/0:0)
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))
DG(a-21:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-21:0)
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)
DG(a-21:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-21:0/0:0)
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))
DG(a-21:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-21:0)
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)
DG(a-21:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-21:0/0:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))
DG(a-21:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-21:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)
DG(a-21:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-21:0/0:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))
DG(a-21:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-21:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)
DG(a-21:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-21:0/0:0)
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))
DG(a-21:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-21:0)
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)
DG(a-21:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-21:0/0:0)
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))
DG(a-21:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-21:0)
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)
DG(i-21:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-21:0/0:0)
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))
DG(i-21:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-21:0)
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)
DG(i-21:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-21:0/0:0)
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))
DG(i-21:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-21:0)
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)
DG(i-21:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-21:0/0:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))
DG(i-21:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-21:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)
DG(i-21:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-21:0/0:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))
DG(i-21:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-21:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)
DG(i-21:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-21:0/0:0)
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))
DG(i-21:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-21:0)
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)
DG(i-21:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-21:0/0:0)
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))
DG(i-21:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-21:0)
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
SM d34:2
Found in mouse lung; TwoDicalId=240; MgfFile=160901_Lung_AA_Neg_17_never; MgfId=745 Found in mouse heart; TwoDicalId=1038; MgfFile=160902_Heart_DHA_Neg_12_never; MgfId=715 Found in mouse spleen; TwoDicalId=448; MgfFile=160729_spleen_AA_18_Neg; MgfId=663 Found in mouse kidney; TwoDicalId=61; MgfFile=160827_Kidney_normal_Neg_01_sute; MgfId=901
(2-{[2-[hexadec-9-enamido]-3-hydroxyoctadec-4-en-1-yl phosphono]oxy}ethyl)trimethylazanium
Crasseride 2a
Crasseride 5
[(4E,8E)-2-(hexadecanoylamino)-3-hydroxyoctadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-hydroxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoxy]propan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-3-hydroxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoate
[1-hydroxy-3-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoxy]propan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[1-hydroxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propan-2-yl] (5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoate
[(4E,8E)-3-hydroxy-2-(nonanoylamino)pentacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-3-hydroxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate
[(E)-2-[[(Z)-hexacos-15-enoyl]amino]-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-3-hydroxy-2-(propanoylamino)hentriaconta-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-3-hydroxy-2-(octanoylamino)hexacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] (8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoate
[(4E,8E)-2-(heptanoylamino)-3-hydroxyheptacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-2-acetamido-3-hydroxydotriaconta-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propan-2-yl] (6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoate
[1-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoxy]-3-hydroxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
[(4E,8E)-2-(hexanoylamino)-3-hydroxyoctacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoxy]-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
[(4E,8E)-2-(butanoylamino)-3-hydroxytriaconta-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-3-hydroxy-2-(pentanoylamino)nonacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoxy]-3-hydroxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
[3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxyoctadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]henicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyheptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxytridecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyheptadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-2-(henicosanoylamino)-3-hydroxytrideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-2-(decanoylamino)-3-hydroxytetracosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-3-hydroxy-2-(undecanoylamino)tricosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]hexadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxydodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-2-(docosanoylamino)-3-hydroxydodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
(2-nonanoyloxy-3-octanoyloxypropyl) (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate
[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-nonanoyloxypropan-2-yl] hexadecanoate
(3-octanoyloxy-2-undecanoyloxypropyl) (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
(3-octanoyloxy-2-pentadecanoyloxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-octanoyloxypropyl] (Z)-heptadec-9-enoate
[3-octanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-nonanoyloxypropyl] (9Z,12Z)-hexadeca-9,12-dienoate
(3-octanoyloxy-2-tridecanoyloxypropyl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
(2-dodecanoyloxy-3-nonanoyloxypropyl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
(2-decanoyloxy-3-nonanoyloxypropyl) (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
(3-nonanoyloxy-2-tetradecanoyloxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-octanoyloxypropyl] heptadecanoate
[3-nonanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-octanoyloxypropyl] (9Z,12Z)-heptadeca-9,12-dienoate
[3-octanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate
[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-nonanoyloxypropan-2-yl] (Z)-hexadec-9-enoate
(3-dodecanoyloxy-2-tridecanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
(3-decanoyloxy-2-tridecanoyloxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
(2-tetradecanoyloxy-3-undecanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[3-dodecanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
(3-decanoyloxy-2-pentadecanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[3-decanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[3-decanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
(3-decanoyloxy-2-undecanoyloxypropyl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
[2-[(Z)-tetradec-9-enoyl]oxy-3-undecanoyloxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
(2-dodecanoyloxy-3-undecanoyloxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
[(E,2S,3R)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyoctadec-4-enyl] 2-[tris(trideuteriomethyl)azaniumyl]ethyl phosphate
[2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-3-hydroxy-2-(pentadecanoylamino)nonadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-3-hydroxy-2-(tridecanoylamino)henicosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-2-(heptadecanoylamino)-3-hydroxyheptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-3-hydroxy-2-(tetradecanoylamino)icosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-2-(dodecanoylamino)-3-hydroxydocosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]icos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-3-hydroxy-2-(octadecanoylamino)hexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-3-hydroxy-2-(icosanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-3-hydroxy-2-(nonadecanoylamino)pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]nonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-[(Z)-dodec-5-enoyl]oxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (4Z,7Z)-hexadeca-4,7-dienoate
[(E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]henicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxydocos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] pentadecanoate
[3-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-2-[(Z)-tridec-8-enoyl]oxypropyl] hexadecanoate
[3-hydroxy-2-[[(10Z,12Z)-octadeca-10,12-dienoyl]amino]hexadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-pentadec-9-enoate
[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-tetradecanoyloxypropyl] (9Z,12Z)-pentadeca-9,12-dienoate
[3-tridecanoyloxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (6Z,9Z,12Z)-pentadeca-6,9,12-trienoate
[2-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-3-dodecanoyloxypropyl] (11Z,14Z)-heptadeca-11,14-dienoate
(3-dodecanoyloxy-2-tridecanoyloxypropyl) (7Z,9Z,11Z,13Z)-hexadeca-7,9,11,13-tetraenoate
2,3-bis[[(Z)-tridec-8-enoyl]oxy]propyl (9Z,12Z)-pentadeca-9,12-dienoate
[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-tridecanoyloxypropyl] (4Z,7Z)-hexadeca-4,7-dienoate
[3-[(Z)-dodec-5-enoyl]oxy-2-tetradecanoyloxypropyl] (6Z,9Z,12Z)-pentadeca-6,9,12-trienoate
[2-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-3-[(Z)-dodec-5-enoyl]oxypropyl] heptadecanoate
[1-[(5Z,8Z,11Z)-tetradeca-5,8,11-trienoyl]oxy-3-[(Z)-tridec-8-enoyl]oxypropan-2-yl] tetradecanoate
[2-[(7Z,9Z)-tetradeca-7,9-dienoyl]oxy-3-tridecanoyloxypropyl] (7Z,9Z)-tetradeca-7,9-dienoate
[3-[(Z)-dodec-5-enoyl]oxy-2-[(5Z,8Z,11Z)-tetradeca-5,8,11-trienoyl]oxypropyl] pentadecanoate
2,3-bis[[(6Z,9Z)-dodeca-6,9-dienoyl]oxy]propyl heptadecanoate
[3-[(Z)-dodec-5-enoyl]oxy-2-[(7Z,9Z)-tetradeca-7,9-dienoyl]oxypropyl] (Z)-pentadec-9-enoate
[3-[(Z)-dodec-5-enoyl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (9Z,12Z)-pentadeca-9,12-dienoate
[3-dodecanoyloxy-2-[(7Z,9Z)-tetradeca-7,9-dienoyl]oxypropyl] (9Z,12Z)-pentadeca-9,12-dienoate
[3-dodecanoyloxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (9Z,11Z,13Z)-hexadeca-9,11,13-trienoate
[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-[(7Z,9Z)-tetradeca-7,9-dienoyl]oxypropyl] pentadecanoate
[3-dodecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (6Z,9Z,12Z)-pentadeca-6,9,12-trienoate
[3-dodecanoyloxy-2-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxypropyl] (Z)-heptadec-7-enoate
[1-[(5Z,8Z,11Z)-tetradeca-5,8,11-trienoyl]oxy-3-tridecanoyloxypropan-2-yl] (Z)-tetradec-9-enoate
[1-[(7Z,9Z)-tetradeca-7,9-dienoyl]oxy-3-[(Z)-tridec-8-enoyl]oxypropan-2-yl] (Z)-tetradec-9-enoate
[3-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-2-tridecanoyloxypropyl] (Z)-hexadec-7-enoate
[2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxyoctadecyl] 2-(trimethylazaniumyl)ethyl phosphate
2,3-bis[[(Z)-dodec-5-enoyl]oxy]propyl (11Z,14Z)-heptadeca-11,14-dienoate
[3-[(Z)-dodec-5-enoyl]oxy-2-tridecanoyloxypropyl] (9Z,11Z,13Z)-hexadeca-9,11,13-trienoate
[3-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-2-tetradecanoyloxypropyl] (Z)-pentadec-9-enoate
[2-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-3-[(Z)-dodec-5-enoyl]oxypropyl] (Z)-heptadec-7-enoate
[3-dodecanoyloxy-2-[(5Z,8Z,11Z)-tetradeca-5,8,11-trienoyl]oxypropyl] (Z)-pentadec-9-enoate
[(E)-3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-dodecanoyloxy-2-[(Z)-dodec-5-enoyl]oxypropyl] (8Z,11Z,14Z)-heptadeca-8,11,14-trienoate
[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (Z)-hexadec-7-enoate
[(E,2S,3R)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]hexadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E,2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxyoctadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E,2S,3R)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E,2S,3R)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxyheptadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E,2S,3R)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxyheptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2S,3R,4E,6E)-3-hydroxy-2-(nonadecanoylamino)pentadeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2S,3R,4E,8E)-3-hydroxy-2-(pentadecanoylamino)nonadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2R,3S,4E,8E)-3-hydroxy-2-(tridecanoylamino)henicosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E,2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E,2S,3R)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]tetradec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2S,3R,4E,8E)-2-(heptadecanoylamino)-3-hydroxyheptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E,2S,3R)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2S,3R,4E,8E)-3-hydroxy-2-(tetradecanoylamino)icosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2R,3S,4E,8E)-2-(dodecanoylamino)-3-hydroxydocosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2S,3R,4E,8E)-2-(hexadecanoylamino)-3-hydroxyoctadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2S,3R,4E,6E)-3-hydroxy-2-(icosanoylamino)tetradeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2S,3R)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]hexadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2S,3R,4E,8E)-3-hydroxy-2-(octadecanoylamino)hexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2S,3R,4E,6E)-3-hydroxy-2-(octadecanoylamino)hexadeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2S,3R,4E,8E)-3-hydroxy-2-(icosanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2S,3R,4E,8E)-3-hydroxy-2-(nonadecanoylamino)pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2S,3R,4E,14E)-2-(hexadecanoylamino)-3-hydroxyoctadeca-4,14-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
2-[Carboxy-(2-heptadecanoyloxy-3-tridecanoyloxypropoxy)methoxy]ethyl-trimethylazanium
2-[Carboxy-[2,3-di(pentadecanoyloxy)propoxy]methoxy]ethyl-trimethylazanium
2-[Carboxy-(2-henicosanoyloxy-3-nonanoyloxypropoxy)methoxy]ethyl-trimethylazanium
2-[Carboxy-(3-decanoyloxy-2-icosanoyloxypropoxy)methoxy]ethyl-trimethylazanium
2-[Carboxy-(2-nonadecanoyloxy-3-undecanoyloxypropoxy)methoxy]ethyl-trimethylazanium
2-[Carboxy-(2-hexadecanoyloxy-3-tetradecanoyloxypropoxy)methoxy]ethyl-trimethylazanium
2-[Carboxy-(3-dodecanoyloxy-2-octadecanoyloxypropoxy)methoxy]ethyl-trimethylazanium
2-[Carboxy-(2-docosanoyloxy-3-octanoyloxypropoxy)methoxy]ethyl-trimethylazanium
N-(9Z-hexadecenoyl)sphingosine-1-phosphocholine
A N-hexadecenoylsphingosine-1-phosphocholine in which the amino group of sphingosine is in amide linkage with a 9Z-hexadecenoyl fatty acid.
N-(tricosanoyl)-[(4E,6E)-tetradecasphingadienine]-1-phosphoethanolamine
A ceramide phosphoethanolamine (37:2) in which the acyl and sphingoid base specified is tricosanoyl and (4E,6E)-tetradecasphingadienine respectively.
N-(docosanoyl)-4E,6E-pentadecasphingadienine-1-phosphoethanolamine
N-(heneicosanoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine
N-(9Z-octadecenoyl)-hexadecasphing-4-enine-1-phosphocholine
N-hexadecanoylsphingadienine-1-phosphocholine
A sphingomyelin 34:2 obtained by formal condensation of the carboxy group of hexadecanoic acid with the amino group of any sphingadienine-1-phosphocholine.
sphingomyelin 34:2
A sphingomyelin in which the total number of carbons in the sphingoid base (R1) and fatty acyl (R2) groups is 34 with 2 double bonds.
ceramide phosphoethanolamine (37:2)
A ceramide phosphoethanolamine in which the sphingoid base and acyl group contains a total of 37 carbon atoms and 2 double bonds.
N-hexadecenoylsphingosine-1-phosphocholine
A sphingomyelin in which the ceramide N-acyl group contains 16 carbons and 1 double bond. A sphingomyelin 34:2 in which the ceramide N-acyl group contains 16 carbons and 1 double bond.
sphingomyelin d18:1/16:1
A sphingomyelin d18:1 in which the fatty acyl group contains 16 carbons and 1 double bond
MGMG(31:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
TG(41:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
BisMePA(35:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved